$308 Million is the total value of ACCIPITER CAPITAL MANAGEMENT, LLC's 8 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 150.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSLA | New | TESLA INCput | $245,552,000 | – | 716,000 | +100.0% | 79.77% | – |
| FELPQ | Buy | FORESIGHT ENERGY LP | $31,592,000 | +17.1% | 7,705,398 | +0.5% | 10.26% | -82.0% |
| CI | Buy | CIGNA CORPORATION COM | $8,498,000 | +44.7% | 50,000 | +42.9% | 2.76% | -77.7% |
| CVS | New | CVS CORPORATION | $6,435,000 | – | 100,000 | +100.0% | 2.09% | – |
| T | New | AT&T INC | $6,422,000 | – | 200,000 | +100.0% | 2.09% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $6,002,000 | – | 100,000 | +100.0% | 1.95% | – |
| TEVA | Sell | TEVA PHARM ADRadr | $2,432,000 | -3.6% | 100,000 | -32.2% | 0.79% | -85.2% |
| SCI | New | SERVICE CORP INTL | $895,000 | – | 25,000 | +100.0% | 0.29% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -80,270 | -100.0% | -25.32% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARM ADR | 17 | Q2 2018 | 21.9% |
| FORESIGHT ENERGY LP | 13 | Q3 2018 | 81.7% |
| SHIRE PLC | 9 | Q1 2018 | 25.3% |
| HEWLETT-PACKARD COMPANY | 7 | Q4 2015 | 17.8% |
| TRIPLE - S MGMT CORP | 5 | Q2 2014 | 49.4% |
| VALEANT PHARMACEUTICALS INTL | 5 | Q4 2016 | 39.1% |
| COMMUNITY HEALTH SYSTEMS | 5 | Q4 2016 | 25.7% |
| KINDRED HEALTHCARE INC | 5 | Q3 2014 | 13.3% |
| PERRIGO CO PLC | 4 | Q4 2016 | 15.2% |
| BIOGEN IDEC INC COM | 4 | Q1 2016 | 12.5% |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foresight Energy LPSold out | February 14, 2020 | 0 | 0.0% |
| TRIPLE-S MANAGEMENT CORP | April 28, 2014 | 118,172 | 4.3% |
| ORCHID CELLMARK INC | May 06, 2011 | 1,581,113 | 5.3% |
| NightHawk Radiology Holdings IncSold out | February 16, 2010 | 0 | 0.0% |
| YM BIOSCIENCES INCSold out | February 16, 2010 | 0 | 0.0% |
| RURAL/METRO CORP /DE/ | January 06, 2010 | 461,351 | 1.8% |
| IMPAX LABORATORIES INC | June 30, 2009 | 140,385 | 0.2% |
| ATHERSYS, INC / NEW | February 17, 2009 | 365,132 | 1.9% |
| ATS MEDICAL INC | February 17, 2009 | 1,161,557 | 1.6% |
| EMAGEON INC | February 17, 2009 | 1,098,984 | 5.1% |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-14 |
| SC 13G/A | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| SC 13G/A | 2018-02-14 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.